RECK and breast carcinoma: Multivariate Cox regression analysis demonstrated that RECK did not provide independent prognostic information for breast cancer patient survival (Tables 2 and 3), strengthening the already reported evidence that this MMP inhibitor is not a relevant biomarker for breast cancer.